spacer
home > ebr > autumn 2017 > avoiding data overload
PUBLICATIONS
European Biopharmaceutical Review

Avoiding Data Overload

Automation is one way of coping with large numbers of repetitive cell screening assays and handling of biological specimens required by the pharmaceutical industry – in the search for new therapeutics, for example. Advances in robotics and computerised equipment, such as microscopes and other technologies, mean that automation is now a more affordable possibility. Full-scale systems incorporate coordinated hardware for practical sample handling protocols linked to software packages for data handling and analysis.

The ability to standardise multiple procedures in automated protocols is particularly advantageous, allowing compliance with enforced statutory regulations of laboratory and manufacturing practice. Such automated workflows have the ability to deliver a high volume of reproducible, high-quality data while saving time and increasing efficiency and accuracy. However, while automation offers many benefits, scientists can often underestimate the significant data load generated by robotic workflows. This can quickly become unmanageable, slowing processes, producing backlogs and ultimately preventing the system from reaching the full capacity for which it was designed.

Careful Planning

The installation of automated systems in a lab is driven by a need to increase output, improve efficiency and, thereby, provide a good return on investment. A build-only solution concentrating on hardware design may appear to be cost-effective, but planning for data handling and analysis during the installation period can save time and expense in the future. The mechanical and computational intricacy of automation systems can be let down by overly complicated operating systems. However, platforms controlled by easy-to-use touch screen interfaces – which require minimal operator training and provide logical step-by-step instructions – are available.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rob Harkness is a Business Development Manager at Peak Analysis and Automation. Here, he is responsible for business and technical development, which involves designing and delivering lab software solutions to the life sciences sector. Rob has over 15 years’ experience in the life sciences automation market and is responsible for leading groups through the full product lifecycle of lab automation products, ensuring efficient integration through analysing requirements and recommending appropriate solutions.
spacer
Rob Harkness
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Avacta develops SARS-COV-2 neutralising Affimer reagents with therapeutic potential for COVID-19

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that several of the Affimer reagents recently generated for development of a point-of-care COVID-19 antigen saliva test have now also been shown to block the interaction between the virus’ spike protein and ACE2, a receptor on human cells that is key to the virus infection pathway1.
More info >>

White Papers

Recommendations Sourcing Human Biospecimens

BioIVT

The foundations for protecting human research subjects come from the ethical principles surrounding the Belmont report : Respect for persons, beneficence, and justice. The use of human biospecimens in research supports these principles with legal and ethical regulations - the most important of which is permission.(1) This permission may come directly from the donor or granted by others with authorization to protect the interests of biospecimen donors.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement